The post Is Eli Lilly Going To $1,100? appeared first on 24/7 Wall St..
Quick Read
Eli Lilly (LLY) reported Q1 2026 revenue of $19.799B, beating consensus by 11.25% with 56% YoY growth, while Non-GAAP EPS of $8.55 crushed the $6.79 estimate.
Mounjaro generated $8.662B in revenue (up 125%), Zepbound contributed $4.16B, and the newly approved oral GLP-1 pill Foundayo beat semaglutide in head-to-head trials on blood sugar and weight loss.
Lilly…